INDmoney
LEGN
Legend Biotech Corp Earnings
$16.65
Earnings Summary
Revenue | $272.33Mn |
Net Profits | $-39.69Mn |
Net Profit Margins | -14.57% |
Legend Biotech Corp’s revenue jumped 69.99% since last year same period to $272.33Mn in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 6.77% jump in its revenue since last 3-months.
Legend Biotech Corp’s net profit jumped 68.33% since last year same period to $-39.69Mn in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 68.35% jump in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin jumped 81.37% since last year same period to -14.57% in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 70.35% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.06 |
EPS Estimate Current Year | -0.06 |
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.06 - a -24.16% fall from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.06.
Key Ratios
Earning Per Share (EPS) | 0 |
Legend Biotech Corp’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Legend Biotech Corp has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-11 | -0.12 | -0.68 | -466.67% |
2025-05-13 | -0.25 | -0.54 | -112.6% |
2026-03-18 | -0.06 | 0 | 100% |
2025-11-12 | -0.04 | -0.11 | -146.09% |
